|Articles|September 15, 2022
Characterizing AAVs with SEC-MALS
Author(s)Wyatt Technology Corporation
SEC-MALS is a platform method for effective product and process development, as well as quality control, of AAVs for gene therapy.
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Related Content
Trending on LCGC International
1
Thermo Fisher and NVIDIA Partner to Expand AI Driven Laboratory Automation
2
Waters Corporation Shareholders Approve Share Issuance for Planned Combination with BD Biosciences and Diagnostics
3
Layer-Resolved Corneal Proteomics Enabled by Laser Ablation Sampling and LC–MS/MS
4
Rapid Native HIC–MS Using Ammonium Tartrate for Robust Drug-to-Antibody Ratio Characterization of Antibody–Drug Conjugates
5